David Kayne

1.5k total citations
5 papers, 363 citations indexed

About

David Kayne is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and General Health Professions. According to data from OpenAlex, David Kayne has authored 5 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Genetics and 1 paper in General Health Professions. Recurrent topics in David Kayne's work include Diabetes Management and Research (5 papers), Diabetes Treatment and Management (4 papers) and Diabetes and associated disorders (2 papers). David Kayne is often cited by papers focused on Diabetes Management and Research (5 papers), Diabetes Treatment and Management (4 papers) and Diabetes and associated disorders (2 papers). David Kayne collaborates with scholars based in United States, Australia and Canada. David Kayne's co-authors include Todd M. Gross, Bruce W. Bode, Daniel Einhorn, John H. Reed, Neil H. White, John J. Mastrototaro, Allen B. King, Xuan Li, Steven V. Edelman and Francisco J. Pasquel and has published in prestigious journals such as Diabetes Technology & Therapeutics, The Diabetes Educator and Journal of Managed Care & Specialty Pharmacy.

In The Last Decade

David Kayne

5 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Kayne United States	4	306	161	117	43	41	5	363
J. Pickup United Kingdom	6	405 1.3×	228 1.4×	179 1.5×	28 0.7×	24 0.6×	7	480
Jort Kropff Netherlands	8	352 1.2×	256 1.6×	180 1.5×	57 1.3×	45 1.1×	8	432
Andrew K. Balo United States	8	295 1.0×	176 1.1×	166 1.4×	37 0.9×	27 0.7×	12	359
Eva Zschornack Germany	11	384 1.3×	196 1.2×	145 1.2×	72 1.7×	30 0.7×	16	486
Erwin S. Budiman United States	7	289 0.9×	175 1.1×	152 1.3×	51 1.2×	36 0.9×	8	363
Narvada Jugnee United Kingdom	9	364 1.2×	273 1.7×	248 2.1×	64 1.5×	27 0.7×	13	489
Ulrike Kamecke Germany	11	193 0.6×	130 0.8×	75 0.6×	70 1.6×	38 0.9×	20	260
Lars Krinelke Germany	7	364 1.2×	205 1.3×	166 1.4×	44 1.0×	11 0.3×	8	428
Mei Mei Church United States	9	323 1.1×	235 1.5×	188 1.6×	24 0.6×	19 0.5×	22	384
Mary Voelmle United States	9	299 1.0×	203 1.3×	155 1.3×	29 0.7×	24 0.6×	10	326

Countries citing papers authored by David Kayne

Since Specialization

Citations

This map shows the geographic impact of David Kayne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kayne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kayne more than expected).

Fields of papers citing papers by David Kayne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Kayne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kayne. The network helps show where David Kayne may publish in the future.

Co-authorship network of co-authors of David Kayne

This figure shows the co-authorship network connecting the top 25 collaborators of David Kayne. A scholar is included among the top collaborators of David Kayne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kayne. David Kayne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Edelman, Steven V., et al.. (2022). Treatment persistence and adherence in people with type 2 diabetes switching to iGlarLixi vs free-dose combinations of basal insulin and glucagon-like peptide 1 receptor agonist. Journal of Managed Care & Specialty Pharmacy. 28(9). 958–968. 10 indexed citations

2.

Johnson, Eric L. & David Kayne. (2020). Implementation of Diabetes Technologies in Primary Care: Challenges and Rewards. Clinical Diabetes. 38(5). 495–500. 1 indexed citations

3.

Gross, Todd M., et al.. (2003). A Bolus Calculator Is an Effective Means of Controlling Postprandial Glycemia in Patients on Insulin Pump Therapy. Diabetes Technology & Therapeutics. 5(3). 365–369. 104 indexed citations

4.

Gross, Todd M., Bruce W. Bode, Daniel Einhorn, et al.. (2000). Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use. Diabetes Technology & Therapeutics. 2(1). 49–56. 240 indexed citations

5.

Sclar, David A., et al.. (1998). Impact on Clinical. Status and Quality of Life of Switching From Regular Insulin to Insulin Lispro Among Patients Using Insulin Pumps. The Diabetes Educator. 24(1). 95–99. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact